Matinas biopharma to webcast conference call to discuss first quarter 2024 financial results and provide a business update on may 9, 2024

Bedminster, n.j., may 02, 2024 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (lnc) platform delivery technology, announces that it will report first quarter 2024 financial results after market close on thursday, may 9, 2024. matinas management will host an investment community conference call and webcast to discuss financial results and provide a business update that day at 4:30 p.m. eastern time (1:30 p.m. pacific time).
MTNB Ratings Summary
MTNB Quant Ranking